Past Lectures

Date Speaker(s) Presentation Title
April 2017

Judith Prochaska, Ph.D., M.P.H.
Stanford Medicine - Stanford University

Digital Tools for Cancer Prevention: Extending Reach and Engagement
April 2017

Steven D. Pearson, M.D., M.Sc., F.R.C.P.
Founder and President, Institute for Clinical Economic Review (ICER), Boston, MA

If Medicare Were to Negotiate Drug Prices, How Would it Determine a ‘Fair’ Price for a Cancer Treatment?
March 2017

Angela Fagerlin, Ph.D.
Professor & Chair, Department of Population Health Sciences, University of Utah

The Impact of Shared Decision-making Interventions on Prostate Cancer Treatment Decision-making
March 2017

Julie R. Palmer, Sc.D.
Boston University

Type 2 Diabetes in Relation to Breast Cancer Risk: Results from the Black Women’s Health Study
March 2017

Kate Sweeny, Ph.D.
University of California, Riverside Riverside, CA

The Psychological Impact of Awaiting Breast Diagnosis: A Preliminary Picture
February 2017

Betty Ferrell, Ph.D., M.A., F.A.A.N., F.P.C.N.
Beckman Research Institute of City of Hope

The Integration of Palliative Care into Standard Oncology Care
January 2017

Jim Evans, M.D., Ph.D.
The University of North Carolina at Chapel Hill

Cancer Prevention, Genomics, and the PMI
January 2017

Andrew Briggs, D.Phil., M.Sc.
University of Glasgow

Designing a value framework for oncology: what are the issues with existing frameworks and can we do better?
January 2017

Shiriki K. Kumanyika, Ph.D., M.P.H.
University of Pennsylvania

Obesity, Cancer Prevention, and Health Equity. The Promise of Public Health Approaches
January 2017

Victoria L. Champion, Ph.D., R.N., F.A.A.N.
Indiana University Simon Cancer Center

How do I develop a program of Cancer Control Science that will make a difference?